Skip to main content

Amyris Partners with Givaudan to Develop Key Fragrance Ingredient from Biofene

Feb 24, 2011

Flavors & Fragrances
Biofene - Farnesene
Synthetic Biology

Amyris, Inc. announced today that it has entered into an agreement with Givaudan, the global leader in the fragrances and flavors industry, headquartered in Vernier, Switzerland. Under the agreement, Givaudan will develop a derivative of Biofene™ to be used as a building block for one of the most important proprietary fragrance ingredients in Givaudan’s palette.

The use of Biofene supports Givaudan’s goal of utilizing cost-effective and sustainably sourced materials. Upon successful achievement of certain success criteria, Amyris will supply Biofene to Givaudan to derive a proprietary fragrance ingredient for the global fragrances and flavors market. Givaudan intends to market and distribute the final product as early as 2012, and Amyris will share in the economic value created from the use of Biofene.

“Our collaboration with Givaudan reinforces our commitment to supply No Compromise® solutions to the fragrances and flavors market,” said John Melo, CEO of Amyris. “This project provides yet another example of the breadth of products that can be derived from Biofene - our first-to-market renewable building block.”

“As an innovator as well as the industry’s largest purchaser of raw materials, we have a responsibility to shape and lead the sustainability approach in the fragrances and flavors industry,” said Gilles Andrier, CEO of Givaudan. “Continued investment into research and development is a key pillar of our 5-year business strategy and through collaborations with suppliers like Amyris, we can deliver real and impactful solutions.”

Amyris’s synthetic biology platform creates living factories to produce specific, targeted molecules. Amyris’s technology platform may be applied to produce an array of ingredients currently used in the fragrances and flavors industry. Amyris designs its No Compromise products to provide high-quality solutions from sustainable and reliable sources and at competitive prices. This collaboration is another indication of Amyris’s potential in the fragrances and flavors market and is the first partnership that focuses on the use of Biofene as a building block for an important fragrances ingredient.

Contact information

Amyris Public Relations
Amyris Public Relations
Job Title
Amyris, Inc
+1 (510) 597-5577
+1 (510) 225-2645
About Amyris, Inc.
Amyris is an integrated renewable products company focused on providing sustainable alternatives to a broad range of petroleum-sourced products. Amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of molecules -- flexible building blocks that can be used in a wide range of products. Amyris’s initial portfolio of commercial products is based on Biofene®, Amyris’s brand of renewable farnesene, a long-chain hydrocarbon. Amyris is commercializing these products both as No Compromise® renewable ingredients in cosmetics, flavors and fragrances, polymers, lubricants and consumer products, and also as No Compromise renewable diesel and jet fuel. Amyris Brasil Ltda., a subsidiary of Amyris, oversees the establishment and expansion of Amyris's production in Brazil. More information about Amyris is available at

Amyris Forward-Looking Statements
This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including those associated with any delays or failures in development, production or commercialization of products, liquidity and ability to fund capital expenditures, Amyris's reliance on third parties to achieve its goals, and other risks detailed in the "Risk Factors" section of Amyris's Form 10-K, as filed annually. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.